Neuroanatomical circuits modulating fear and anxiety behaviors

Acta Psychiatrica Scandinavica, Supplement

Volumn 108, Issue 417, 2003, Pages 38-50

  Charney, D S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety; Fear; Neuroanatomical circuits; Neurobiology

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; CHOLECYSTOKININ; CORTICOTROPIN RELEASING FACTOR; NORADRENALIN; SEROTONIN; DIAZEPAM; FLUMAZENIL; IOMAZENIL; NEUROTRANSMITTER;

AMYGDALOID NUCLEUS; ANXIETY DISORDER; CONFERENCE PAPER; DEPRESSION; GENETICS; HUMAN; IMAGING SYSTEM; LIMBIC CORTEX; NEUROANATOMY; NEUROBIOLOGY; NEUROCHEMISTRY; PANIC; PATHOPHYSIOLOGY; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PROVOCATION TEST; TEMPORAL CORTEX; CINGULATE GYRUS; FEAR; HORMONE RELEASE; INSULA; LIMBIC SYSTEM; NEUROIMAGING; NEUROPHYSIOLOGY; PRIORITY JOURNAL; SENSORY SYSTEM;

EID: 0141517336     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.108.s417.3.x     Document Type: Conference Paper

References (180)

1. LEDOUX J. Fear and the brain: where have we been, and where are we going? Biol Psychiatry 1998;44:1229-1238.
2. DAVIS M. Are different parts of the extended amygdala involved in fear versus anxiety? Biol Psychiatry 1998;44:1239-1247.
3. LEDOUX JE. Emotion. In: MILLS J, MOUNTCASTLE VB, PLUM F et al, eds. Handbook of physiology - the nervous system V. Baltimore, MD: Williams & Wilkins, 1987:373-417.
4. ROGAN MT, STAUBLI UV, LEDOUX JE. Fear conditioning induces associative long-term potentiation in the amygdala. Nature 1997;390:604-607.
5. PRICE JL, CARMICHAEL ST, DREVETS WC. Networks related to the orbital and medial prefrontal cortex: a substrate for emotional behavior? Prog Brain Res 1996;107:523-536.
6. DORON NN, LEDOUX JE. Organization of projections to the lateral amygdala from auditory and visual areas of the thalamus in the rat. J Comp Neurol 1999;412:383-409.
7. GRAY JA, McNAUGHTON N. The neuropsychology of anxiety: reprise. Nebr Symp Motiv 1996;43:61-134.
8. PHILLIPS RG, LEDOUX JE. Lesions of the fornix but not the entorhinal or perirhinal cortex interfere with contextual fear conditioning. J Neurosci 1995;15:5308-5315.
9. LEDOUX JE, ROMANSKI L, XAGORARIS A. Indelibility of subcortical emotional memories. J Cogn Neurosci 1989;1:238-243.
10. SHI C, DAVIS M. Pain pathways involved in fear conditioning measured with fear-potentiated startle: lesion studies. J Neurosci 1999;19:420-430.
11. PITKANEN A, SAVANDER V, LEDOUX JE. Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci 1997;20:517-523.
12. PITKANEN A, STEFANACCI L, FARB CR et al. Intrinsic connections of the rat amygdaloid complex: projections originating in the lateral nucleus. J Comp Neurol 1995;356:288-310.
13. SAVANDER V, MIETTINEN R, LEDOUX JE et al. Lateral nucleus of the rat amygdala is reciprocally connected with basal and accessory basal nuclei: a light and electron microscopy study. Neuroscience 1997;77:767-781.
14. FERRY B, ROOZENDAAL B, McGAUGH JL. Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala. Biol Psychiatry 1999;46:1140-1152.
15. LEDOUX JE. Emotion: clues from the brain. Annu Rev Psychol 1995;46:209-235.
16. MAREN S. Long-term potentiation in the amygdala: a mechanism for emotional learning and memory. Trends Neurosci 1999;22:561-567.
17. MURRAY EA. Memory for objects in nonhuman primates. In: GAZZANIGA MS, ed. The new cognitive neurosciences. Cambridge, MA: MIT Press 2000:753-763.
18. SQUIRE LR, KNOWLTON BJ. Learning about categories in the absence of memory. Proc Natl Acad Sci USA 1995;92:12470-12474.
19. CANLI T, ZHAO Z, BREWER J et al. Event-related activation in the human amygdala associates with later memory for individual emotional experience. J Neurosci 2000;20:RC99.
20. PHELPS EA, ANDERSON AK. Emotional memory: what does the amygdala do? Curr Biol 1997;7:R311-R314.
21. HALGREN E. The amygdala contribution to emotion and memory: current studies in humans. In: BEN-ARI Y, ed. The amygdaloid complex. New York: Elsevier, 1981:395-408.
22. GLOOR P, OLIVIER A, QUESNEY LF et al. The role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982;12:129-144.
23. BROTHERS L. Neurophysiology of the perception of intentions by primates. In: GAZZANIGA MS, ed. The cognitive neurosciences. Cambridge, MA: MIT Press, 1995:1107-1116.
24. KRETTEK JE, PRICE JL. Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat. J Comp Neurol 1977;172:723-752.
25. RAUCH SL, SAVAGE CR, ALPERT NM et al. A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry 1995;52:20-28.
26. RAUCH SL, VAN DER KOLK BA, FISLER RE et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 1996;53:380-387.
27. LANE RD, REIMAN EM, AHERN GL et al. Neuroanatomical correlates of happiness, sadness, and disgust. Am J Psychiatry 1997;154:926-933.
28. REIMAN EM, LANE RD, AHERN GL et al. Neuroanatomical correlates of externally and internally generated human emotion. Am J Psychiatry 1997;154:918-925.
29. BAXTER MG, PARKER A, LINDNER CC et al. Control of response selection by reinforcer value requires interaction of amygdala and orbital prefrontal cortex. J Neurosci 2000;20:4311-4319.
30. DAMASIO AR, GRABOWSKI TJ, BECHARA A et al. Neural correlates of the experience of emotions. Soc Neurosci Abstract 1998;24:258.
31. ROGERS RD, EVERITT BJ, BALDACCHINO A et al. Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-deleted normal volunteers: evidence for monoaminergic mechanisms. Neuropsychopharmacology 1999;20:322-339.
32. ROLLS ET. Learning mechanisms in the temporal lobe visual cortex. Behav Brain Res 1995;66:177-185.
33. GARCIA R, VOUIMBA RM, BAUDRY M et al. The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature 1999;402:294-296.
34. MORGAN MA, LEDOUX JE. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci 1995;109:681-688.
35. ÖNGÜR D, PRICE JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex 2000;10:206-219.
36. QUIRK GJ, RUSSO GK, BARRON JL et al. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci 2000;20:6225-6231.
37. DREVETS WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-829.
38. DREVETS WC, RAICHLE ME. Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: implications for interactions between emotion and cognition. Cogn Emotion 1998;12:353-385.
39. CARMICHAEL ST, PRICE JL. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol 1995;363:615-641.
40. LEICHNETZ GR, ASTRUC J. The efferent projections of the medial prefrontal cortex in the squirrel monkey (Saimiri sciureus). Brain Res 1976;109:455-472.
41. DAMASIO AR, TRANEL D, DAMASIO H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res 1990;41:81-94.
42. DOLAN RJ, FLETCHER P, MORRIS J et al. Neural activation during covert processing of positive emotional facial expressions. Neuroimage 1996;4:194-200.
43. DREVETS WC, VIDEEN TO, SNYDER AZ et al. Regional cerebral blood flow changes during anticipatory anxiety. Soc Neurosci Abstract 1994;20:368.
44. DREVETS WC, BOTTERON K. Neuroimaging in psychiatry. In: GUZE SB, ed. Adult psychiatry. St. Louis, MO: Mosby, 1997:53-81.
45. MOGENSON GJ, BRUDZYNSKI SM, WU M et al. From motivation to action: a review of dopaminergic regulation of limbic, nucleus accumbens, ventral pallidum, pedunculopontine nucleus circuitries involved in limbic-motor integration. In: KALIVAS PW, BARNES CD, eds. Limbic motor circuits and neuropsychiatry. London: CRC Press, 1993:193-236.
46. BECHARA A, DAMASIO H, DAMASIO AR. Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 2000;10:295-307.
47. MADDOCK RJ. The retrosplenial cortex and emotion: new insights from functional imaging of the human brain. Trends Neurosci 1999;22:310-316.
48. REIMAN E, RAICHLE MF, BUTLER K et al. A focal brain abnormality in panic disorder, a severe form of anxiety. Nature 1984;310:683-685.
49. NORDAHL TE, SEMPLE WE, GROSS M et al. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology 1990;3:261-272.
50. BISAGA A, KATZ JL, ANTONINI A et al. Cerebral glucose metabolism in women with panic disorder. Am J Psychiatry 1998;155:1178-1183.
51. DE CRISTOFARO MT, SESSAREGO A, PUPI A et al. Brain perfusion abnormalities in drug-na, lactate-sensitive panic patients: a SPECT study. Biol Psychiatry 1993;33:505-512.
52. REIMAN EM, RAICHLE ME, ROBINS E et al. Neuroanatomical correlates of a lactate-induced anxiety attack. Arch Gen Psychiatry 1989;46:493-500.
53. RAUCH SL, SAVAGE CR, ALPERT NM et al. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997;42:446-452.
54. BENKELFAT C, BRADWEJN J, MEYER E et al. Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers. Am J Psychiatry 1995;152:1180-1184.
55. DREVETS WC, SIMPSON JR, RAICHLE ME. Regional blood flow changes in response to phobic anxiety and habituation. J Cereb Blood Flow Metab 1995;15:S856.
56. RAUCH SL, JENIKE MA, ALPERT NM et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
57. SCHNEIDER F, WEISS U, KESSLER C et al. Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatry 1999;45:863-871.
58. LIBERZON I, TAYLOR SF, AMDUR R et al. Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 1999;45:817-826.
59. SHIN LM, MCNALLY RJ, KOSSLYN SM et al. Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: a PET investigation. Am J Psychiatry 1999;156:575-584.
60. SHIN LM, KOSSLYN SM, MCNALLY RJ et al. Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry 1997;54:233-241.
61. BREMNER JD, KRYSTAL JH, SOUTHWICK SM et al. Noradrenergic mechanisms in stress and anxiety. I. Preclinical studies. Synapse 1996;23:28-38.
62. BREMNER JD, KRYSTAL JH, SOUTHWICK SM et al. (1996b) Noradrenergic mechanisms in stress and anxiety. II. Clinical studies. Synapse 1996;23:39-51.
63. RAUCH SL, WHALEN PJ, SHIN LM et al. Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000;47:769-776.
64. BREMNER JD, RANDALL P, SCOTT TM et al. MRI-based measurement hippocampal volume patients with combat-related posttraumatic stress disorder. Amer J Psych 1995;152:973-981.
65. BREMNER JD, RANDALL P, VERMETTEN E et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biol Psychiatry 1997;41:23-32.
66. GURVITS TV, SHENTON ME, HOKAMA H et al. Magnetic resonance imaging study of hippocampal volume in chronic combat-related posttraumatic stress disorder. Biol Psychiatry 1996;40:1091-1099.
67. STEIN MB, KOVEROLA C, HANNA C et al. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med 1997;27:951-959.
68. CASSENS G, KURUC A, ROFFMAN M et al. Alterations in brain norepinephrine metabolism and behavior induced by environmental stimuli previously paired with inescapable shock. Behav Brain Res 1981;2:387-407.
69. RASMUSSEN K, MORILAK DA, JACOBS BL. Single unit activity of locus coeruleus neurons in the freely moving cat. I. During naturalistic behaviors and in response to simple and complex stimuli. Brain Res 1986;371:324-334.
70. REDMOND DF Jr. Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In: MELTZER HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:967-975.
71. ABERCROMBIE ED, JACOBS BL. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats I. Acutely presented stressful and nonstressful stimuli. J Neurosci 1987;7:2837-2843.
72. CHARNEY DS, HENINGER GR, BREIER A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1984;41:751-763.
73. CHARNEY DS, WOODS SW, GOODMAN WK et al. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 1987;144:1030-1036.
74. GRILLON C, MORGAN CA. Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. J Abnorm Psych 1999;108:134-142.
75. ASTON-JONES G, SHIPLEY MT, CHOUVET G et al. Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology. Prog Brain Res 1991;88:47-75.
76. PRINS A, KALOUPCK DG, KEANE TM. Psychophysiological evidence for autonomic arousal and startle in traumatized adult populations. In: FRIEDMAN MJ, CHARNEY DS, DEUTCH AY, eds. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. New York: Raven Press, 1995:291-314.
77. BANDELOW B, SENGOS G, WEDEKIND D et al. Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder. Pharmacopsychiatry 1997;30:113-117.
78. WILKINSON D, THOMPSON JM, LAMBERT GW et al. Sympathetic activity in patients with panic disorder at rest, under laboratory mental stress, and during panic attacks. Arch Gen Psychiatry 1998;55:511-520.
79. UHDE TW, JOFFE RT, JIMERSON DC et al. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications. Biol Psychiatry 1988;23:575-585.
80. NUTT DJ. Altered central alpha2-adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry 1989;46:165-169.
81. COPLAN JD, PINE D, PAPP L et al. Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients. Neuropsychopharmacology 1995;13:65-73.
82. COPLAN JD, PAPP LA, MARTINEZ JA et al. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder. Am J Psychiatry 1995;152:619-622.
83. GURGUIS GN, UHDE TW. Plasma 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and growth hormone responses to yohimbine in panic disorder patients and normal controls. Psychoneuroendocrinology 1990;15:217-227.
84. GURGUIS GN, VITTON BJ, UHDE TW. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res 1997;71:27-39.
85. ALBUS M, ZAHN TP, BRIER A. Anxiogenic properties of yohimbine: behavioral, physiological and biochemical measures. Eur Arch Psychiatry Clin Neurosci 1992;241:337-344.
86. CAMERON OG, ZUBIETA JK, GRUNHAUS L et al. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosom Med 2000;62:549-559.
87. CHARNEY DS, WOODS SW, KRYSTAL JH et al. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr Scand 1992;86:273-282.
88. YERAGANI VK, BERGER R, POHL R et al. Effects of yohimbine on heart rate variability in panic disorder patients and normal controls: a study of power spectral analysis of heart rate. J Cardiovasc Pharmacol 1992;20:609-618.
89. BREMNER JD, INNIS RB, NG CK et al. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 1997;54:246-254.
90. SOUTHWICK SM, KRYSTAL JH, MORGAN CA et al. Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:266-274.
91. SOUTHWICK SM, KRYSTAL JH, BREMNER JD et al. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch Gen Psychiatry 1997;54:749-758.
92. LEMIEUX AM, COE CL. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women Psychosom Med 1995;57:105-115.
93. HAWK LW, DOUGALL AL, URSANO RJ et al. Urinary catecholamines and cortisol in recent-onset posttraumatic stress disorder after motor vehicle accidents. Psychosom Med 2000;62:423-434.
94. DE BELLIS MD, BAUM AS, BIRMAHER B et al. A.E. Bennett Research Award. Developmental traumatology. Part I. Biological stress systems. Biol Psychiatry 1999;45:1259-1270.
95. MCFALL ME, VEITH RC, MURBURG MM. Basal sympatho-adrenal function in posttraumatic stress disorder. Biol Psychiatry 1992;31:1050-1056.
96. BLANCHARD EB, KOLB LC, PRINS A et al. Changes in plasma norepinephrine to combat-related stimuli among Vietnam veterans with posttraumatic stress disorder. J Nerv Ment Dis 1991;179:371-373.
97. GERACIOTI TD, BAKER DG, EKHATOR NN et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001;158:1227-1230.
98. SAPOLSKY RM, PLOTSKY PM. Hypercortisolism and its possible neural bases. Biol Psychiatry 1990;27:937-952.
99. KANT GJ, LEU JR, ANDERSON SM et al. Effects of chronic stress on plasma corticosterone, ACTH and prolactin. Physiol Behav 1987;40:775-779.
100. IRWIN J, AHLUWALIA P, ZACHARKO RM et al. Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling. Pharmacol Biochem Behav 1986;24:1151-1154.
101. DALLMAN MF, JONES MT. Corticosteroid feedback control of ACTH secretion: effect of stress-induced corticosterone secretion on subsequent stress responses in the rat. Endocrinology 1973;92:1367-1375.
102. STANTON ME, GUTIERREZ YR, LEVINE S. Maternal deprivation potentiates pituitary-adrenal stress responses in infant rats. Behav Neurosci 1988;102:692-700.
103. LEVINE S, WIENER SG, COE CL. Temporal and social factors influencing behavioral and hormonal responses to separation in mother and infant squirrel monkeys. Psychoneuroendocrinology 1993;18:297-306.
104. LIU D, DIORIO J, TANNENBAUM B et al. Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997;277:1659-1662.
105. PLOTSKY PM, MEANEY MJ. Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median CRF content and stress-induced release in adult rats. Mol Brain Res 1993;18:195-200.
106. HEIM C, WOENS MJ, PLOTSKY PM et al. Persistent changes in corticotropin-releasing factor systems due to early life stress: relationship to pathophysiology of major depression and post-traumatic stress disorder. Psychopharmacol Bull 1997;33:185-192.
107. COPLAN JD, ROSENBLUM LA, ANDREWS MW et al. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc Natl Acad Sci USA 1996;93:1619-1623.
108. MEANEY MJ, AITKEN DH, VAN BERKEL C et al. Effect of neonatal handling on age-related impairments associated with the hippocampus. Science 1988;239:766-768.
109. MEANEY MJ, AITKEN DH, VIAU V et al. Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 1989;50:597-604.
110. SCHULKIN J, GOLD PW, MCEWEN BS. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 1998;23:219-243.
111. MAKINO S, GOLD PW, SCHULKIN J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 1994;640:105-112.
112. MAKINO S, GOLD PW, SCHULKIN J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 1994;657:141-149.
113. MAKINO S, SCHULKIN J, SMITH MA et al. Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucortoids and stress. Endocrinology 1995;136:4517-4525.
114. SWANSON LW, SIMMONS DM. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J Comp Neurol 1989;285:413-435.
115. KOOB GF, HEINRICHS SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 1999;848:141-152.
116. SMITH GW, AUBREY JM, DELLU F et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 1998;20:1093-1102.
117. TIMPL P, SPANAGEL R, SILLABER I et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor. Nat Genet 1998;19:162-166.
118. BALE TL, CONTARINO A, SMITH GW et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 2000;24:410-414.
119. KISHIMOTO T, RADULOVIC J, RADULOVIC M et al. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 2000;24:415-419.
120. HABIB KE, WELD KP, RICE KC et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci USA 2000;97:6079-6084.
121. MASON JW, GILLER EL, KOSTEN TR et al. Urinary free-cortisol levels in post-traumatic stress disorder patients. J Nerv Ment Dis 1986;174:145-149.
122. YEHUDA R, BOISONEAU D, LOWY MT et al. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 1995;52:583-593.
123. YEHUDA R, BIERER LM, SCHMEIDLER J et al. Low cortisol and risk for PTSD in adult offspring of holocaust survivors. Am J Psychiatry 2000;157:1252-1259.
124. LIBERZON I, ABELSON JL, FLAGEL SB et al. Neuroendocrine and psychophysiological responses in PTSD: a symptom provocation study. Neuropsychopharmacology 1999;21:40-50.
125. MAES M, LIN A, BONACCORSO S, VAN HUNSEL F et al. Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand 1998;98:328-335.
126. PITMAN RK, ORR SP. Twenty-four hour urinary cortisol and catecholamine excretion in combat-related posttraumatic stress disorder. Biol Psychiatry 1990;27:245-247.
127. YEHUDA R, LOWY MT, SOUTHWICK SM et al. Lymphocyte glucocorticoid receptor number in posttraumatic stress disorder. Am J Psychiatry 1991;148:499-504.
128. KOSTEN TR, WAHBY V, GILLER EL et al. The dexamethasone suppression test and thyrotropin-releasing hormone stimulation test in posttraumatic stress disorder. Biol Psychiatry 1990;28:657-664.
129. YEHUDA R, SOUTHWICK SM, KRYSTAL JH et al. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am J Psychiatry 1993;150:83-86.
130. STEIN MB, YEHUDA R, KOVEROLA C et al. Enhanced dexamethasone suppression of plasma cortisol in adult women traumatized by childhood sexual abuse. Biol Psychiatry 1997;42:680-686.
131. YEHUDA R, TEICHER MH, TRESTMAN RL et al. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996;40:79-88.
132. BREMNER JD, LICINIO J, DARNELL A et al. Elevated CSF corticotropin-releasing factor concentrations in posttraumatric stress disorder. Am J Psychiatry 1997;154:624-629.
133. BAKER DG, WEST SA, NICHOLSON WE et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder. Am J Psychiatry 1999;156:585-588.
134. SMITH MA, DAVIDSON J, RITCHIE JC et al. The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry 1989;26:349-355.
135. HEIM C, NEWPORT D J, HEIT S et al. Pituitary - adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000;284:592-597.
136. NUTT DJ, GLUE P, LAWSON C, WILSON S. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder. Arch Gen Psychiatry 1990;47:917-925.
137. ROY-BYRNE P, WINGERSON DK, RADANT A et al. Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects. Am J Psychol 1996;153:1444-1449.
138. WOODS SW, CHARNEY DS, SILVER JM et al. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Res 1991;36:115-127.
139. ROY-BYRNE PP, LEWIS N, VILLACRES E et al. Preliminary evidence of benzodiazepine subsensitivity in panic disorder. Biol Psychiatry 1989;26:744-748.
140. SCHLEGEL S, STEINERT H, BOCKISCH A et al. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci 1994;244:49-51.
141. KASHCKA W, FEISTEL H, EBERT D. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT. J Psychiatr Res 1995;29:427-434.
142. KUIKKA JT, PITKANEN A, LEPOLA U et al. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder. Nucl Med Commun 1995;16:273-280.
143. BREMNER JD, INNIS RB, WHITE T et al. SPECT [I-123] iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry 2000;47:96-106.
144. A-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 1998;55:715-720.
145. ABADIE P, BOULENGER JP, BENALI K et al. Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study. Eur J Neurosci 1999;11:1470-1478.
146. NORMAN TR, JUDD FK, GREGORY M et al. Platelet serotonin uptake in panic disorder. J Affect Disord 1986;11:69-72.
147. BALON R, POHL R, YERAGANI V et al. Platelet serotonin levels in panic disorder. Acta Psychiatr Scand 1987;75:315-317.
148. PECKNOLD JC, SURANYI-CADOTTE B, CHANG H et al. Serotonin uptake in panic disorder and agoraphobia. Neuropsychopharmacology 1988;1:173-176.
149. 3H]imipramine binding in patients with panic disorder. Biol Psychiatry 1987;22:52-58.
150. INNIS RB, CHARNEY DS, HENINGER GR. Differential 3H-imipramine platelet binding in patients with panic disorder and depression. Psychiatry Res 1987;21:33-41.
151. 3H]imipramine binding in generalized anxiety disorder, panic disorder, and agoraphobia with panic attacks. Biol Psychiatry 1987;22:59-66.
152. CHARNEY DS, HENINGER GR. Serotonin function in panic disorders. The effects of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment. Arch Gen Psychiatry 1986;43:1059-1065.
153. DEN BOER JA, WESTENBERG HG. Behavioral, neuroendocrine, and biochemical effects of 5hydroxytryptophan administration in panic disorder. Psychiatry Res 1990;31:267-278.
154. GODDARD AW, SHOLOMSKAS DE, WALTON KE et al. Effects of tryptophan depletion in panic disorder. Biol Psychiatry 1994;36:775-777.
155. TARGUM SD, MARSHALL LE. Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 1989;28:295-306.
156. MEYER JH, SWINSON R, KENNEDY SH et al. Increased left posterior parietal-temporal cortex activation after D-fenfluramine in women with panic disorder. Psychiatry Res 2000;98:133-143.
157. HARRO J, VASAR E, BRADWEJN J. CCK in animal and human research on anxiety. Trends Pharmacol Sci 1993;14:244-249.
158. BRADWEJN J, KOSZYCKI D. Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 1994;151:261-263.
159. KELLNER M, WIEDEMANN K, YASSOURIDIS A et al. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol Psychiatry 2000;47:107-111.
160. STROHLE A, HOLSBOER F, RUPPRECHT R. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder. Neuropsychopharmacology 2000;22:251-256.
161. LYDIARD RB, BALLENGER JC, LARAIA MT et al. CSF cholecystokinan concentrations in patients with panic disorder and in normal comparison subjects. Am J Psychiatry 1992;149:691-693.
162. RODRIGUES SM, SCHAFE GE, LEDOUX JE. Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci 2001;21:6889-6896.
163. BAUER EP, SCHAFE GE, LEDOUX JE. NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci 2002;22(12):5239-5249.
164. MCGAUGH JL. Memory consolidation and the amygdala: a system perspective. Trends Neurosci 2002;25:456-461.
165. ROOZENDALL B, BRUNSON KL, HOLLOWAY BL, MCGAUGH JL, BARAM TZ. Involvement of stress-released corticotrophin-releasing hormone in the basolateral amygdala in regulating memory consolidation. PNAS 2002;99:13908-13913.
166. DEBIEC J, LEDOUX JE, NADER K. Cellular and systems reconsolidation in the hippocampus. Neuron 2002;36:527-538.
167. MILEKIC MH, ALBERINI CM. Temporally graded requirement for protein synthesis following memory reactivation. Neuron 2002;36:521-525.
168. MYERS KM, DAVIS M. Systems-level reconsolidation: re-engagement of the hippocampus with memory reactivation. Neuron 2002;36:340-343.
169. MILAD MR, QUIRK GJ. Neurons in medial prefrontal cortex signal memory for fear extinction. Nature 2002;420:70-74.
170. HERRY C, GARCIA R. Prefrontal cortex long-term potentiation but not long-term depression is associated with maintenance of extinction of learned fear in mice. J Neurosci 2002;22:577-583.
171. MADDOCK RJ, BUONOCORE MH, KILE SJ, GARRETT AS. Brain regions showing increased activation by threat-related words in panic disorder. Neuroreport 2003, 14:325-328.
172. STEIN MB, GOLDIN PR, SAREEN J, ZORRILLA LT, BROWN GG. Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 2002;59:1027-1034.
173. BREMNER JD, VYTHILINGAM M, VERMETTEN E, SOUTHWICK SM, MCGLASHAN T, NAZEER A, KHAN S, VACCARINO LV, SOUFER R, GARG PK, NG CK, STAIB LH, DUNCAN JS, CHARNEY DS. MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder. Am J Psychiatry 2003;160:924-932.
174. RAUCH SL, SHIN LM, SEGAL E, PITMAN RK, CARSON MA, MCMULLIN K, WHALEN PJ, MAKRIS N. Selectively reduced regional cortical volumes in post-traumatic stress disorder. Neuroreport 2003;14:913-916.
175. SCHWARTZ CE, WRIGHT CI, SHIN LM, KAGAN J, RAUCH SL. Inhibited and unhibited infacts "grown up": adult amygdalar response to novelty. Science 2003;300:1952-1953.
176. SHUMYATSKY G, TSVETKOV E, MALLERET G, VRONSKAYA S, HORTON M, HAMPTON L, BATTEY JF, DULAC C, KANDEL ER, BOLSHAKOV VY. Identification of a signalling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear. Cell 2002;111:905-918.
177. GILBERTSON MW, SHENTON ME, CIZEWSKI A, KASAI K, LASKO NB, ORR SP, PITMAN RK. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat Neurosci 2002;5:1242-1247.
178. HAMILTON SP, FYER AJ, DURNER M, HEIMAN GA, BAISRE DE LEON A, HODGE SE, KNOWLES JA, WEISSMAN MM. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 2003;100:2550-2555.
179. THORGEIRSSON TE, HOGNI O, DESNICA N, KOSTIC JP, STEFANSSON JG, KOLBEINSOON H, LINDAL E, GAGUNASHVILI N, FRIGGE ML, KONG A, STEFANSSON K, GULCHER JR. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am J Hum Genet 2003;72:1221-1230.
180. CHARNEY DS. Psychobiological mechanisms of resilience and vulnerability: Implications for the successful adaptation to extreme stress. Am J Psychiatry 2003, in press.